000 | 01073 a2200277 4500 | ||
---|---|---|---|
005 | 20250516064828.0 | ||
264 | 0 | _c20130712 | |
008 | 201307s 0 0 eng d | ||
022 | _a1433-8726 | ||
024 | 7 |
_a10.1007/s00345-011-0798-5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aYates, David R | |
245 | 0 | 0 |
_aComparing how significantly the pharmacological treatment of genitourinary cancer in a non-curative setting affects endpoints of survival or response. _h[electronic resource] |
260 |
_bWorld journal of urology _cFeb 2013 |
||
300 |
_a117-25 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPalliative Care _xmethods |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aUrogenital Neoplasms _xdrug therapy |
700 | 1 | _aRouprĂȘt, Morgan | |
773 | 0 |
_tWorld journal of urology _gvol. 31 _gno. 1 _gp. 117-25 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00345-011-0798-5 _zAvailable from publisher's website |
999 |
_c21335574 _d21335574 |